论文部分内容阅读
目的了解漯河市2012-2013年涂阳肺结核治疗转归情况,为结核病预防控制决策提供参考。方法收集漯河市2012-2013年结核病登记资料及国家结核病专报信息系统等有关资料,参照《中国结核病防治规划实施工作指南》要求进行总结分析。结果漯河市2012-2013年2 333例登记新涂阳肺结核中,疗程末治愈病人248例,平均治愈率91.54%,完成疗程4例,完成疗程率1.62%;拒绝治疗14例,拒治率5.65%。两年间疗程末痰涂片阴转情况接近,治愈率相同(x2=0.92,P>0.05),同时完成疗程率也有升高(x2=0.23,P>0.05),但是拒绝治疗的病人比例有所降低(x2=3.623,P<0.05)。结论结核病防控是一项系统化的社会性公共卫生服务工作,对新涂阳肺结核的治疗具有长期性和持续性,要严密关注结核病人的治疗依从性,加强治疗督导管理工作,特别是应加强对伴有药品不良反应、合并有其它疾患、经济贫困病人的随访管理,强化治疗前门诊宣传教育工作。建议对于复治、耐药病人在按照《结核病控制工作指南》进行统一治疗管理的情况下,可根据患者个人情况给予个体化辅助治疗。
Objective To understand the outcome of the treatment of smear-positive pulmonary tuberculosis in Luohe city from 2012 to 2013 and provide a reference for the prevention and control decision-making of tuberculosis. Methods Collecting information about tuberculosis registration and national TB information system of 2012-2013 in Luohe City, and summarizing and analyzing according to the requirements of Guidelines for Implementation of TB Prevention and Cure Program in China. Results In 2 333 cases of new smear-positive pulmonary tuberculosis registered in Luohe from 2012 to 2013, 248 cases were cured at the end of the course of treatment, with an average cure rate of 91.54%. Four cases were completed and the completion rate was 1.62%. Refusal treatment was performed in 14 cases and rejection rate was 5.65 %. Two years of treatment at the end of sputum smear negative conversion close to the same cure rate (x2 = 0.92, P> 0.05), while the completion of the treatment rate also increased (x2 = 0.23, P> 0.05), but refused to treat the proportion of patients Decreased (x2 = 3.623, P <0.05). Conclusion Tuberculosis prevention and control is a systematic social public health service. It has long-term and sustained treatment of new smear-positive pulmonary tuberculosis. It is necessary to pay close attention to the treatment compliance of tuberculosis patients and strengthen the supervision and management of treatment. In particular, Strengthen the follow-up management of patients with adverse drug reactions, mergers and other illnesses, and economically disadvantaged patients, and strengthen the out-patient publicity and education before treatment. Recommendations for retreatment, resistant patients in accordance with the “Tuberculosis Control Guide” for unified treatment and management of cases, according to individual patients can be given individualized adjuvant therapy.